↓ Skip to main content

OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal

Overview of attention for article published in Frontiers in oncology, February 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users
patent
15 patents
facebook
1 Facebook page

Citations

dimensions_citation
198 Dimensions

Readers on

mendeley
283 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal
Published in
Frontiers in oncology, February 2015
DOI 10.3389/fonc.2015.00034
Pubmed ID
Authors

Stefanie N. Linch, Michael J. McNamara, William L. Redmond

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 283 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Australia 1 <1%
Singapore 1 <1%
Belgium 1 <1%
Denmark 1 <1%
Korea, Republic of 1 <1%
United States 1 <1%
Unknown 276 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 96 34%
Student > Ph. D. Student 39 14%
Student > Bachelor 24 8%
Student > Master 20 7%
Student > Doctoral Student 19 7%
Other 37 13%
Unknown 48 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 56 20%
Immunology and Microbiology 48 17%
Medicine and Dentistry 45 16%
Biochemistry, Genetics and Molecular Biology 37 13%
Pharmacology, Toxicology and Pharmaceutical Science 12 4%
Other 28 10%
Unknown 57 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2023.
All research outputs
#1,836,025
of 25,374,917 outputs
Outputs from Frontiers in oncology
#367
of 22,416 outputs
Outputs of similar age
#22,673
of 271,284 outputs
Outputs of similar age from Frontiers in oncology
#3
of 95 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,416 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,284 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.